BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:NGENLA (somatrogon) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of NGENLA (somatrogon)\, from ClinicalTrials
 .gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07226089-10909@assetmemo.bio
DTSTAMP:20261121T005436Z
DTSTART;VALUE=DATE:20271231
DTEND;VALUE=DATE:20280101
SUMMARY:NGENLA (somatrogon): Phase 3 readout est. (NCT07226089)
DESCRIPTION:NGENLA (somatrogon)\, phase 3.\nStudy: Comparison of Weekly Som
 atrogon to Daily Genotropin in Children Born Small for Gestational Age or 
 With Idiopathic Short Stature.\nEstimated primary completion: December 202
 7. This is a ClinicalTrials.gov estimate\, not a confirmed readout date\, 
 and it can move.\nDrug page: https://assetmemo.bio/drug/somatrogon#upcomin
 g-events\nRegistry record: https://clinicaltrials.gov/study/NCT07226089
URL:https://assetmemo.bio/drug/somatrogon#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
